Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

The Novel JAK Inhibitor CYT387 Suppresses Multiple Signalling Pathways, Prevents Proliferation and Induces Apoptosis in Phenotypically Diverse Myeloma Cells

Leukemia

English

‘Educational Symposium on Long-Term Results of Large Prospective Clinical Trials for Childhood Acute Lymphoblastic Leukemia (1985–2000)’

English

Effects of the Small-Molecule Inhibitor of Integrin Α4, TBC3486, on Pre-B-All Cells

English

Diffuse MRI Marrow Pattern Correlates With Increased Angiogenesis, Advanced Disease Features and Poor Prognosis in Newly Diagnosed Myeloma Treated With Novel Agents

English

Impact of Graft-Versus-Host Disease After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

English

Comment on Structural Basis of DUX4/IGH-driven Transactivation

English

Mutations of the Epigenetics-Modifying Gene (DNMT3a, TET2, IDH1/2) at Diagnosis May Induce FLT3-ITD at Relapse in De Novo Acute Myeloid Leukemia

English

Risk Factors for Tumor Lysis Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With the Cyclin-Dependent Kinase Inhibitor, Flavopiridol

English

Natural Killer Cell Lymphoma Shares Strikingly Similar Molecular Features With a Group of Non-Hepatosplenic Γδ T-Cell Lymphoma and Is Highly Sensitive to a Novel Aurora Kinase a Inhibitor in Vitro

English

Bone Marrow Stem Cell Mobilization in Stroke: A ‘Bonehead’ May Be Good After All!

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

The Novel JAK Inhibitor CYT387 Suppresses Multiple Signalling Pathways, Prevents Proliferation and Induces Apoptosis in Phenotypically Diverse Myeloma Cells

‘Educational Symposium on Long-Term Results of Large Prospective Clinical Trials for Childhood Acute Lymphoblastic Leukemia (1985–2000)’

Effects of the Small-Molecule Inhibitor of Integrin Α4, TBC3486, on Pre-B-All Cells

Diffuse MRI Marrow Pattern Correlates With Increased Angiogenesis, Advanced Disease Features and Poor Prognosis in Newly Diagnosed Myeloma Treated With Novel Agents

Impact of Graft-Versus-Host Disease After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Comment on Structural Basis of DUX4/IGH-driven Transactivation

Mutations of the Epigenetics-Modifying Gene (DNMT3a, TET2, IDH1/2) at Diagnosis May Induce FLT3-ITD at Relapse in De Novo Acute Myeloid Leukemia

Risk Factors for Tumor Lysis Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With the Cyclin-Dependent Kinase Inhibitor, Flavopiridol

Natural Killer Cell Lymphoma Shares Strikingly Similar Molecular Features With a Group of Non-Hepatosplenic Γδ T-Cell Lymphoma and Is Highly Sensitive to a Novel Aurora Kinase a Inhibitor in Vitro

Bone Marrow Stem Cell Mobilization in Stroke: A ‘Bonehead’ May Be Good After All!